Introduction: Cirrhosis is a public health problem and the causes are dominated by viral hepatitis and alcoholism. Deaths due to cirrhosis represented 2.4% of deaths worldwide in 2017. The aim of this work was to study the diagnostic and prognosis of cirrhosis at the department of internal medicine of the Abass Ndao hospital center. Patients and Methods: This is a retrospective, descriptive study, carried out on the basis of patient files followed from May 1, 1999 to February 28, 2018 (19 years) and included all patients for whom the diagnosis of cirrhosis was accepted. The diagnosis of cirrhosis was made on the basis of clinical, biological and ultrasound (portal hypertension, signs of hepatocellular insufficiency, a diffuse heterogeneous aspect, and irregularity of the liver contours). Results: 60 patient files were listed with an average age of 46.9 years, a sex ratio of 2.2 and alcoholism in 11.7% of the cases. The reasons for consultation were dominated by an increase in the size of the abdomen (55%), lose weight (50%). On physical examination, it was a hepatomegaly (43.3%) and jaundices (33.3%). Exploration of liver function showed a cholestasis (48%), a cytolysis (58%) and a hepatocellular insufficiency (46.2%). Anemia was found in (24%). The abdominal ultrasound found in all cases a dysmorphic, heterogeneous liver with irregular contours. Hepatic atrophy was found in 20%. Among the 34 patients who underwent upper gastrointestinal endoscopy, they were grade 2 to 3 esophageal varicose vein in 67.6%, an erosive gastropathy in 29.4%. The etiology was viral hepatitis B in 45%, alcoholism in 11.7% and undetermined in 43.3%. A hematemesis complicated the evolution in 16.7%. Carcinomatous degeneration was found in 5% and 16.7% of the patients had died. Conclusion: our experience with cirrhosis was marked by advanced forms at the stage of complications. The viral etiology B remains dominant. Prevention will involve early detection and vaccination.
References
[1]
Anthony, P.P., Ishak, K.G., Nayak, N.C., Poulsen, H.E., Scheuer, P.J. and Sobin, L.H. (1978) The Morphology of Cirrhosis. Recommendations on Definition, Nomenclature, and Classification by a Working Group Sponsored by the World Health Organization. Journal of Clinical Pathology, 31, 395-414. https://doi.org/10.1136/jcp.31.5.395
[2]
Ge, P.S. and Runyon, B.A. (2016) Treatment of Patients with Cirrhosis. The New England Journal of Medicine, 375, 767-777. https://doi.org/10.1056/NEJMra1504367
[3]
Sepanlou, S.G., Safiri, S., Bisignano, C., Ikuta, K.S., Merat, S., Saberifiroozi, M. and Abdoli, A. (2020) The Global, Regional, and National Burden of Cirrhosis by Cause in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 5, 245-266. https://doi.org/10.1016/S2468-1253(19)30349-8
[4]
Roth, G.A., Abate, D., Abate, K.H., et al. (2018) Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1736-1788. https://doi.org/10.1016/S0140-6736(18)32203-7
[5]
Dia, D., Serme, Y.K., Bassène, M.L., Halim, A., Diallo, S., Thioubou, M.A., Mbengue, M. and Diouf, M.L. (2014) Spontaneous Bacterial Peritonitis in Dakar, Senegal: Study of 55 Patients with Cirrhosis. Medecine et Sante Tropicales, 24, 55-57. https://doi.org/10.1684/mst.2013.0260
[6]
Diarra, M., Konaté, A., Soukho, A., Dicko, M., Kallé, A., Doumbia, K., et al. (2010) Evolutionary Aspects of Cirrhotic Disease in a Hepatogastroenterology Department in Mali. Le Mali Médical, 1, 42-46.
[7]
Duah, A., Nkrumah, K.N. and Tachi, K. (2018) Oesophageal Varices in Patients with Liver Cirrhosis Attending a Major Tertiary Hospital in Ghana. The Pan African Medical Journal, 31, 230. https://doi.org/10.11604/pamj.2018.31.230.16657
[8]
Apica, B., Ocama, P., Seremba, E., Opio, K. and Kagimu, M. (2013) Decompensated Cirrhosis-Related Admissions in a Large Urban Hospital in Uganda: Prevalence, Clinical and Laboratory Features and Implications for Planning Patient Management. African Health Sciences, 13, 927-932. https://doi.org/10.4314/ahs.v13i4.10
[9]
Montano-Loza, A.J., Meza-Junco, J., Prado, C.M., Lieffers, J.R., Baracos, V.E., Bain, V.G., et al. (2012) Muscle Wasting Is Associated with Mortality in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology, 10, 166-173. https://doi.org/10.1016/j.cgh.2011.08.028
[10]
Condat, B., Remy, A.J., Jouannaud, V., Lahmek, P., Rosa, I., Cadranel, J.F., et al. (2012) The Use of Cirrhosis Care in the Hepato-Gastroenterology Departments of French General Hospitals in 2012. Bulletin épidémiologique Hebdomadaire, 24-25, 450-456.
[11]
Allan, R., Thoirs, K. and Phillips, M. (2010) Accuracy of Ultrasound to Identify Chronic Liver Disease. World Journal of Gastroenterology, 16, 3510-3520. https://doi.org/10.3748/wjg.v16.i28.3510
[12]
Maiga, M.Y., Dembele, M., Diallo, F., Traore, H.A., Traore, A.K. and Guindo, A. (2002) Upper Digestive Endoscopy in the Diagnosis of Cirrhosis. Acta Endoscopica, 32, 211-218. https://doi.org/10.1007/BF03016657
[13]
Nwokediuko, S.C., Osuala, P.C., Uduma, U.V., Alaneme, A.K., Onwuka, C.C. and Mesigo, C. (2013) Pattern of Liver Disease Admissions in a Nigerian Tertiary Hospital. Nigerian Journal of Clinical Practice, 16, 339-342. https://doi.org/10.4103/1119-3077.113458
[14]
Chalasani, N.P., Hayashi, P.H., Bonkovsky, H.L., Navarro, V.J., Lee, W.M. and Fontana, R.J. (2014) ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. American Journal of Gastroenterology, 109, 950-966. https://doi.org/10.1038/ajg.2014.131
[15]
Chalasani, N. and Pariente, A. (2006) Ascitic Decompensation. Gastroentérologie Clinique et Biologique, 30, 870-874. https://doi.org/10.1016/S0399-8320(06)73334-6
[16]
Garcia-Tsao, G. (2005) Bacterial Infections in Cirrhosis: Treatment and Prophylaxis. Journal of Hepatology, 42, S85-S92. https://doi.org/10.1016/j.jhep.2004.12.006
[17]
Wiest, R. and Garcia-Tsao, G. (2005) Bacterial Translocation (BT) in Cirrhosis. Hepatology, 41, 422-433. https://doi.org/10.1002/hep.20632
[18]
Wiegand, J. and Berg, T. (2013) The Etiology, Diagnosis and Prevention of Liver Cirrhosis. Deutsches Ärzteblatt International, 110, 85-91. https://doi.org/10.3238/arztebl.2013.0085
[19]
Pagliaro, L., D’Amico, G., Pasta, L., Malizia, G., Tinè, F., Traina, M., et al. (1994) Portal Hypertension in Cirrhosis: Natural History. In: Bosch, J. and Groszmann, R., Eds., Portal Hypertension: Pathophysiology and Treatment, Backwell Scientific, Cambridge, 72-92.
[20]
Tarao, K., Nozaki, A., Ikeda, T., Sato, A., Komatsu, H., Komatsu, T. and Tanaka, K. (2019) Real Impact of Liver Cirrhosis on the Development of Hepatocellular Carcinoma in Various Liver Diseases-Meta-Analytic Assessments. Cancer Medicine, 8, 1054-1065. https://doi.org/10.1002/cam4.1998
[21]
Moosa, S.V. and Müllhauptb, B. (2015) Hepatic Cirrhosis: Potential Progression and Regression. Swiss Medical Forum, 15, 100-105.
[22]
Leon, D.A. and McCambridge, J. (2006) Liver Cirrhosis Mortality Rates in Britain from 1950 to 2002: An Analysis of Routine Data. The Lancet, 367, 650. https://doi.org/10.1016/S0140-6736(06)67924-5
